Demonstrações financeiras detalhadas de Myriad Genetics, Inc. (MYGN): demonstração de resultados, balanço patrimonial e fluxo de caixa. Acompanhe a evolução de margens, dívida, liquidez e rentabilidade ano a ano com até 20 anos de histórico.
Resumo da Análise
Myriad Genetics, Inc. registou receitas de $824.5M no último exercício, com um CAGR de 5 anos de 8.2%.
Margens dos últimos 12 meses: margem bruta 68.8%, margem operacional -12.2%, margem líquida -14.0%.
Ao preço atual de $3.86, MYGN apresenta lucros negativos (P/L não significativo) e um ROE de -32.59%. A capitalização de mercado é de $365M.
Demonstração de Resultados (10 anos)
| Ano | 2017 | 2018 | 2019 | 2020 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Receita | $728.7M | $743.7M | $851.1M | $638.6M | $557.0M | $690.6M | $678.4M | $753.2M | $837.6M | $824.5M |
| Custo da Receita | $171.2M | $177.2M | $201.0M | $186.1M | $178.2M | $197.6M | $202.0M | $236.2M | $252.2M | $247.9M |
| Lucro Bruto | $557.5M | $566.5M | $650.1M | $452.5M | $378.8M | $493.0M | $476.4M | $517.0M | $585.4M | $576.6M |
| P&D | $74.4M | $70.8M | $85.9M | $77.2M | $80.9M | $81.9M | $85.4M | $88.7M | $113.4M | $106.8M |
| Despesas Gerais e Administrativas | $439.9M | $435.0M | $556.6M | $507.3M | $500.7M | $537.8M | $514.7M | $572.9M | $560.0M | $537.6M |
| Despesas Operacionais | $513.5M | $444.6M | $642.5M | $684.2M | $653.3M | $683.5M | $600.1M | $661.6M | $673.4M | $644.4M |
| Lucro Operacional | $44.0M | $121.9M | $7.6M | -$231.7M | -$194.8M | -$190.5M | -$123.7M | -$144.6M | -$88.0M | -$67.8M |
| EBITDA | $90.5M | $177.7M | $85.0M | -$140.5M | -$123.4M | $12.3M | -$84.7M | -$197.4M | -$59.5M | -$330.9M |
| Despesas com Juros | $6.0M | $3.2M | $12.0M | $10.8M | 0 | $6.6M | $3.2M | $2.9M | $2.8M | $10.5M |
| Lucro Antes de Impostos | $36.2M | $120.1M | 0 | -$223.3M | -$283.7M | -$57.1M | -$140.6M | -$262.2M | -$123.5M | -$395.1M |
| Imposto | $19.0M | -$13.0M | -$4.4M | -$23.7M | -$59.9M | -$29.9M | -$28.6M | $1.1M | $3.8M | -$29.2M |
| Lucro Líquido | $17.4M | $133.3M | $4.6M | -$199.5M | -$223.7M | -$27.2M | -$112.0M | -$263.3M | -$127.3M | -$365.9M |
| LPA | $0.32 | $1.89 | $0.06 | $-2.69 | $-2.99 | $-0.35 | $-1.39 | $-3.18 | $-1.41 | $-3.96 |
| LPA Diluído | $0.32 | $1.82 | $0.06 | $-2.69 | $-2.99 | $-0.35 | $-1.39 | $-3.18 | $-1.41 | $-3.96 |
| Ações em Circulação (Diluídas) | $68.8M | $72.0M | $76.0M | $74.3M | $74.8M | $78.0M | $80.6M | $82.8M | $90.6M | $93.3M |
Demonstração de Resultados (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Receita | $205.7M | $209.8M | $200.4M | $190.7M |
| Lucro Bruto | $143.8M | $146.8M | $137.6M | $127.0M |
| Lucro Operacional | -$23.3M | -$5.7M | -$30.7M | -$38.9M |
| EBITDA | -$9.8M | $8.1M | -$17.5M | -$26.0M |
| Lucro Líquido | -$27.4M | -$7.9M | -$34.1M | -$43.2M |
| LPA | $-0.29 | $-0.08 | $-0.36 | $-0.46 |
| LPA Diluído | $-0.29 | $-0.08 | $-0.36 | $-0.46 |
Balanço (10 anos)
| Ano | 2017 | 2018 | 2019 | 2020 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caixa e Equivalentes | $102.4M | $110.9M | $93.2M | $163.7M | $117.0M | $257.4M | $56.9M | $132.1M | $102.4M | $149.6M |
| Investimentos de Curto Prazo | $48.3M | $69.7M | $43.7M | $54.1M | $33.7M | $81.4M | $58.0M | $8.8M | 0 | 0 |
| Contas a Receber | $95.9M | $103.3M | $138.6M | $71.0M | $89.5M | $91.3M | $101.6M | $114.3M | $121.2M | $115.3M |
| Estoque | $42.2M | $34.3M | $31.4M | $29.1M | $27.1M | $15.3M | $20.1M | $22.0M | $27.5M | $30.6M |
| Ativos Circulantes | $301.7M | $327.6M | $348.6M | $331.7M | $389.4M | $484.8M | $274.6M | $313.6M | $298.0M | $332.6M |
| Imobilizado | $51.1M | $43.2M | $57.3M | $103.0M | $100.4M | $125.3M | $187.3M | $180.6M | $172.4M | $163.4M |
| Ágio | $316.1M | $318.6M | $417.2M | $327.6M | $329.2M | $239.2M | $286.8M | $287.4M | $286.3M | $51.6M |
| Ativos Intangíveis | $491.5M | $455.2M | $684.7M | $605.3M | $578.8M | $404.1M | $379.7M | $349.5M | $262.4M | $153.4M |
| Ativos Totais | $1.21B | $1.18B | $1.56B | $1.40B | $1.42B | $1.32B | $1.20B | $1.15B | $1.03B | $706.6M |
| Contas a Pagar | $22.0M | $26.0M | $33.3M | $21.7M | $20.5M | $29.6M | $28.8M | $25.8M | $32.3M | $30.0M |
| Dívida de Curto Prazo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passivos Circulantes | $217.5M | $102.2M | $117.8M | $147.0M | $145.9M | $204.3M | $137.2M | $155.9M | $164.1M | $133.8M |
| Dívida de Longo Prazo | $99.1M | $9.3M | $233.5M | $224.4M | $224.8M | 0 | 0 | $38.5M | $39.6M | $119.9M |
| Passivos Totais | $440.9M | $209.2M | $473.8M | $486.4M | $537.8M | $352.9M | $312.9M | $363.3M | $326.5M | $338.6M |
| Reservas | -$78.2M | $54.1M | $25.6M | -$173.9M | -$227.0M | -$254.2M | -$366.2M | -$629.5M | -$756.8M | -$1.12B |
| Patrimônio Líquido | $768.4M | $966.1M | $1.09B | $918.2M | $881.0M | $967.8M | $885.8M | $783.2M | $701.1M | $368.0M |
| Dívida Total | $99.1M | $9.3M | $233.5M | $294.8M | $289.0M | $92.3M | $145.0M | $152.1M | $140.3M | $209.8M |
| Dívida Líquida | -$51.6M | -$171.3M | $96.6M | $77.0M | $138.3M | -$246.5M | $30.1M | $11.2M | $37.9M | $60.2M |
| Capital de Giro | $84.2M | $225.4M | $230.8M | $184.7M | $243.5M | $280.5M | $137.4M | $157.7M | $133.9M | $198.8M |
Balanço (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caixa e Equivalentes | $145.4M | $149.6M | $124.4M | $115.2M |
| Ativos Totais | $728.1M | $706.6M | $673.7M | $638.9M |
| Passivos Totais | $355.3M | $338.6M | $336.3M | $335.0M |
| Patrimônio Líquido | $372.8M | $368.0M | $337.4M | $303.9M |
| Dívida Total | $212.3M | $209.8M | $211.5M | $210.5M |
Fluxo de Caixa (10 anos)
| Ano | 2017 | 2018 | 2019 | 2020 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Lucro Líquido | $17.4M | $133.3M | $4.6M | -$199.5M | -$223.7M | -$27.2M | -$112.0M | -$263.3M | -$127.3M | -$365.9M |
| Depreciação e Amortização | $48.3M | $54.4M | $73.0M | $72.0M | $71.4M | $62.8M | $52.7M | $61.9M | $61.2M | $53.7M |
| Compensação em Ações | $29.9M | $27.1M | $33.5M | $25.2M | $24.3M | $36.3M | $38.1M | $40.7M | $49.8M | $35.2M |
| Variação Capital de Giro | $5.6M | $8.5M | -$39.4M | $117.9M | $30.2M | $120.8M | -$83.5M | $27.0M | -$54.4M | -$19.3M |
| Fluxo de Caixa Operacional | $106.2M | $115.9M | $83.7M | $60.7M | -$26.9M | $18.6M | -$106.3M | -$110.9M | -$8.7M | $1.8M |
| CapEx | -$6.1M | -$8.4M | -$8.6M | -$10.2M | -$13.2M | -$18.0M | -$45.3M | -$73.3M | -$29.7M | -$27.4M |
| Aquisições | -$216.1M | 0 | -$278.5M | $21.3M | 0 | $379.1M | -$57.2M | 0 | $8.8M | 0 |
| Recompra de Ações | -$31.6M | 0 | -$50.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fluxo de Caixa Livre | $100.1M | $107.5M | $75.1M | $50.5M | -$40.1M | $600000 | -$151.6M | -$184.2M | -$38.4M | -$25.6M |
Fluxo de Caixa (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Fluxo de Caixa Operacional | $21.1M | $10.6M | -$15.7M | -$8.3M |
| CapEx | -$2.8M | -$6.0M | -$5.4M | -$2.1M |
| Fluxo de Caixa Livre | $18.3M | $4.6M | -$21.1M | -$10.4M |
| Dividendos Pagos | 0 | 0 | 0 | 0 |
| Compensação em Ações | $12.2M | $2.8M | $6.5M | $7.2M |
Crescimento e Margens (10 anos)
| Ano | 2017 | 2018 | 2019 | 2020 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crescimento Receita (anual) | | +2.1% | +14.4% | -25.0% | -12.8% | +24.0% | -1.8% | +11.0% | +11.2% | -1.6% |
| Crescimento Lucro Líquido (anual) | | +666.1% | -96.5% | -4437.0% | -12.1% | +87.8% | -311.8% | -135.1% | +51.7% | -187.4% |
| Crescimento LPA (anual) | | +490.6% | -96.7% | -4390.3% | -11.4% | +88.3% | -297.1% | -128.8% | +55.7% | -180.9% |
| Variação de Ações (anual) | | +4.7% | +5.6% | -2.2% | +0.6% | +4.3% | +3.3% | +2.7% | +9.4% | +3.0% |
| Crescimento FCF (anual) | | +7.4% | -30.1% | -32.8% | -179.4% | +101.5% | -25366.7% | -21.5% | +79.2% | +33.3% |
| Margem Bruta | 76.5% | 76.2% | 76.4% | 70.9% | 68.0% | 71.4% | 70.2% | 68.6% | 69.9% | 69.9% |
| Margem Operacional | 6.0% | 16.4% | 0.9% | -36.3% | -35.0% | -27.6% | -18.2% | -19.2% | -10.5% | -8.2% |
| Margem EBITDA | 12.4% | 23.9% | 10.0% | -22.0% | -22.2% | 1.8% | -12.5% | -26.2% | -7.1% | -40.1% |
| Margem Líquida | 2.4% | 17.9% | 0.5% | -31.2% | -40.2% | -3.9% | -16.5% | -35.0% | -15.2% | -44.4% |
| Margem FCF | 13.7% | 14.5% | 8.8% | 7.9% | -7.2% | 0.1% | -22.3% | -24.5% | -4.6% | -3.1% |
| Taxa Efetiva de Imposto | 52.5% | -10.8% | | 10.6% | 21.1% | 52.4% | 20.3% | -0.4% | -3.1% | 7.4% |
Dados por Ação (10 anos)
| Ano | 2017 | 2018 | 2019 | 2020 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Ação | $1.45 | $1.49 | $0.99 | $0.68 | $-0.54 | $0.01 | $-1.88 | $-2.22 | $-0.42 | $-0.27 |
| Dividendo por Ação | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Ações em Circulação (Básicas) | $68.3M | $69.4M | $73.5M | $74.3M | $74.7M | $77.7M | $80.6M | $82.8M | $90.6M | $93.3M |
O que olhar em Saúde / Farma
O pipeline de I+D é o ativo invisível. Patentes a caducar = receitas a evaporar. Olha inovação e fluxo de caixa.
- I+D / Receita — Indica investimento em pipeline futuro. Farma séria reinveste 15-20%
- Crescimento EPS 5 anos — Após expiração de patentes, ainda crescem?
- Margem bruta — Farma de marca >70%. Genéricos muito mais baixo — define o tipo de negócio
- FCF / Net Income — Qualidade do lucro — farma grande deveria converter >90%
- ROIC — Capital reinvestido com eficiência — chave em farma por ciclos longos de I+D
- Dívida líquida / EBITDA — Aquisições farmacêuticas geram muita dívida — atenção ao pós-M&A
- P/E vs histórico 10 anos próprio — A melhor comparação é com o próprio histórico, não com pares
Rentabilidade
| Retorno sobre patrimônio | -32.59% |
| Retorno sobre capital investido | -19.13% |
| Retorno sobre ativos | -17.62% |
| Margem bruta | 68.83% |
| Margem operacional | -12.22% |
| Margem líquida | -13.96% |
Saúde financeira
| Dívida / Patrimônio | 0.69 |
| Liquidez corrente | 2.21 |
Índices Chave (10 anos)
| Ano | 2017 | 2018 | 2019 | 2020 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/L | 80.75 | 19.77 | 439.24 | -4.22 | -6.61 | -78.86 | -10.44 | -6.02 | -9.72 | -1.55 |
| P/VP | 2.30 | 2.68 | 1.86 | 0.92 | 1.68 | 2.22 | 1.32 | 2.02 | 1.77 | 1.56 |
| P/V | 2.42 | 3.49 | 2.37 | 1.32 | 2.65 | 3.11 | 1.72 | 2.10 | 1.48 | 0.70 |
| Margem Bruta | 76.5% | 76.2% | 76.4% | 70.9% | 68.0% | 71.4% | 70.2% | 68.6% | 69.9% | 69.9% |
| Margem Operacional | 6.0% | 16.4% | 0.9% | -36.3% | -35.0% | -27.6% | -18.2% | -19.2% | -10.5% | -8.2% |
| Margem Líquida | 2.4% | 17.9% | 0.5% | -31.2% | -40.2% | -3.9% | -16.5% | -35.0% | -15.2% | -44.4% |